SERA LOGO.jpg
Key Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in Biotechnology
February 12, 2018 08:00 ET | Sera Prognostics, Inc.
SEATTLE and SALT LAKE CITY, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Sera Prognostics, a women’s health company, in collaboration with The Institute for Systems Biology and Integrated Diagnostics (Indi),...
SERA LOGO.jpg
Sera Prognostics to Present at the 11th Annual Canaccord Genuity Medical Technologies and Diagnostics Forum
November 06, 2017 10:00 ET | Sera Prognostics, Inc.
SALT LAKE CITY, Nov. 06, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
SERA LOGO.jpg
Sera Prognostics to Present at the Baird 2017 Global Healthcare Conference
September 05, 2017 10:49 ET | Sera Prognostics, Inc.
SALT LAKE CITY, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive...
Sera Prognostics is Named a 2017 Silver Edison Award Winner
April 21, 2017 07:00 ET | Sera Prognostics, Inc.
NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- The Edison Awards, celebrating 30 years of honoring the best in innovation and excellence in the development of new products and services, announced...
Sera Prognostics to Present at 35th Annual J.P. Morgan Healthcare Conference
January 03, 2017 10:00 ET | Sera Prognostics, Inc.
SALT LAKE CITY, Jan. 03, 2017 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that Gregory C. Critchfield, M.D., M.S., Chairman and Chief Executive Officer,...
Landmark Study Published in American Journal of Obstetrics & Gynecology Validates New Blood Test as Objective, Predictive Tool for Preterm Birth Risk
March 10, 2016 07:00 ET | Sera Prognostics, Inc.
SALT LAKE CITY, March 10, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that clinical validation data from the 5,501 patient Proteomic Assessment of...
Positive Clinical Validation Data for PreTRM® Test Presented at the Society for Maternal-Fetal Medicine’s 36th Annual Pregnancy Meeting
February 04, 2016 15:15 ET | Sera Prognostics, Inc.
SALT LAKE CITY, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., a women’s healthcare company, today announced that results from the 5,501-patient Proteomic Assessment of Preterm Risk...
HGH Infrared Systems' Spynel-S Soars as part of a multi-sensor unmanned solution at the 2015 International Paris Air Show
July 09, 2015 10:37 ET | HGH Infrared Systems
BOSTON, July 9, 2015 (GLOBE NEWSWIRE) -- At the 51st edition of the International Paris Air Show this year, the world's largest and oldest aerospace trade show, HGH Infrared Systems' Spynel-S was...
Stellar Biotechnologies Announces Significant Expansion of Keyhole Limpet Hatchery & Sera Production Capability
December 06, 2011 09:18 ET | Stellar Biotechnologies, Inc.
PORT HUENEME, CA--(Marketwire - Dec 6, 2011) - Stellar Biotechnologies, Inc. ("Stellar") (TSX VENTURE: KLH) (PINKSHEETS: SBOTF) is pleased to announce the completion of a major expansion of its...